Feb 24, 2021

Featuring an interview with Dr Erika Hamilton on the following topics:

• Management of ER-positive metastatic breast cancer (0:00)
• Case: A woman in her early 60s with de novo ER-positive metastatic breast cancer develops a rash while receiving a PI3K inhibitor (24:08)
• Case: A woman in her early 60s receives an oral SERD...

Feb 22, 2021

Featuring an interview with Dr Kathleen Moore on the following topics:

• Recent data with PARP inhibitors and immune checkpoint inhibitors for advanced ovarian cancer (0:00)
• Efficacy of lenvatinib alone and in combination with pembrolizumab in patients with previously treated ovarian cancer (34:23)
• Activity of...

Feb 20, 2021

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Hematologic Cancers — Multiple Myeloma — Faculty Presentation 1: Consolidation and Maintenance Therapy in Newly Diagnosed MM — Role of MRD Testing — Dr Fonseca.
CME information and...

Feb 20, 2021

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Hematologic Cancers — Multiple Myeloma — Faculty Presentation 2: Other Novel Strategies with Potential to Improve Outcomes in MM — Dr Landgren.
CME information and select publications

Feb 20, 2021

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Hematologic Cancers — Multiple Myeloma — Faculty Presentation 3: Selection and Sequencing of Available and Recently Approved Therapies for Patients with Relapsed/Refractory MM —...